Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Superior antitumor immunotherapy efficacy of kynureninase modified CAR-T cells through targeting kynurenine metabolism
Authors
Keywords
-
Journal
OncoImmunology
Volume 11, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2022-03-26
DOI
10.1080/2162402x.2022.2055703
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tryptophan and Kynurenine Enhances the Stemness and Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stromal Cells In Vitro and In Vivo
- (2021) Hai Pham et al. Materials
- In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8+ T cell fate decisions
- (2021) Hongling Huang et al. CELL
- Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy
- (2021) Robert D. Leone et al. Cancer Immunology Research
- Utilization of Metabolite Identification and Structural Data to Guide Design of Low-Dose IDO1 Inhibitors
- (2021) Brett Hopkins et al. ACS Medicinal Chemistry Letters
- Kynurenine induces T cell fat catabolism and has limited suppressive effects in vivo
- (2021) Peter J. Siska et al. EBioMedicine
- Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors
- (2020) Xiaohan Song et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- CAR T cells: continuation in a revolution of immunotherapy
- (2020) Anurag K Singh et al. LANCET ONCOLOGY
- Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma
- (2020) Jennifer N. Brudno et al. NATURE MEDICINE
- Immunometabolic Network Interactions of the Kynurenine Pathway in Cutaneous Malignant Melanoma
- (2020) Soudabeh Rad Pour et al. Frontiers in Oncology
- Engineering CAR-T Cells for Next-Generation Cancer Therapy
- (2020) Mihe Hong et al. CANCER CELL
- A Fas-4-1BB fusion protein converts a death to a pro-survival signal and enhances T cell therapy
- (2020) Shannon K. Oda et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IDO Expression in Cancer: Different Compartment, Different Functionality?
- (2020) Annabel Meireson et al. Frontiers in Immunology
- IDO1 Expression in Melanoma Metastases Is Low and Associated With Improved Overall Survival
- (2020) Kevin T. Lynch et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies
- (2020) Nashwa El-Khazragy et al. Immunotherapy
- Effect of Taxane Chemotherapy With or Without Indoximod in Metastatic Breast Cancer
- (2020) Veronica Mariotti et al. JAMA Oncology
- Metabolic Dynamics of In Vitro CD8+ T Cell Activation
- (2020) Joy Edwards-Hicks et al. Metabolites
- IDO1 and Kynurenine Pathway Metabolites Activate PI3K-Akt Signaling in the Neoplastic Colon Epithelium to Promote Cancer Cell Proliferation and Inhibit Apoptosis
- (2019) Kumar S. Bishnupuri et al. CANCER RESEARCH
- Chimeric antigen receptor T cell persistence and memory cell formation
- (2019) Alexander D McLellan et al. IMMUNOLOGY AND CELL BIOLOGY
- Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
- (2019) Zixun Yan et al. CLINICAL CANCER RESEARCH
- Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study
- (2019) Georgina V Long et al. LANCET ONCOLOGY
- Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma
- (2019) Arghya Ray et al. LEUKEMIA
- Lactate up-regulates the expression of PD-L1 in kidney and causes immunosuppression in septic Acute Renal Injury
- (2019) Jingjing Xu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Targeting the Kynurenine Pathway for the Treatment of Cisplatin-Resistant Lung Cancer
- (2019) Dan J. M. Nguyen et al. MOLECULAR CANCER RESEARCH
- Metabolomic adaptations and correlates of survival to immune checkpoint blockade
- (2019) Haoxin Li et al. Nature Communications
- Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma
- (2019) Soudabeh Rad Pour et al. Scientific Reports
- Reversal of indoleamine 2,3-dioxygenase–mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme
- (2018) Todd A Triplett et al. NATURE BIOTECHNOLOGY
- Suppression of antitumor T cell immunity by the oncometabolite (R)-2-hydroxyglutarate
- (2018) Lukas Bunse et al. NATURE MEDICINE
- A prospective evaluation of serum kynurenine metabolites and risk of pancreatic cancer
- (2018) Joyce Y. Huang et al. PLoS One
- Double-slit photoelectron interference in strong-field ionization of the neon dimer
- (2018) Maksim Kunitski et al. Nature Communications
- Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22
- (2018) Haiying Qin et al. Molecular Therapy-Oncolytics
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma
- (2017) Giuseppe Lucarelli et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- Driving CAR T-cells forward
- (2016) Hollie J. Jackson et al. Nature Reviews Clinical Oncology
- Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
- (2015) Chih-Hao Chang et al. CELL
- High serum concentration of L-kynurenine predicts unfavorable outcomes in patients with acute myeloid leukemia
- (2015) Ryoko Mabuchi et al. LEUKEMIA & LYMPHOMA
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
- (2015) Adrienne H Long et al. NATURE MEDICINE
- Glucose Metabolism Regulates T Cell Activation, Differentiation, and Functions
- (2015) Clovis S. Palmer et al. Frontiers in Immunology
- Kynurenine and uric acid levels in chronic myeloid leukemia patients
- (2015) Vladimir Vonka et al. OncoImmunology
- Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
- (2014) D. A. Wainwright et al. CLINICAL CANCER RESEARCH
- Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
- (2013) Chih-Hao Chang et al. CELL
- Kynurenine is an endothelium-derived relaxing factor produced during inflammation
- (2010) Yutang Wang et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now